Men who drink one normal-sized soft drink per day are at greater risk of getting more aggressive forms of prostate cancer, according to a Swedish study released Monday.
More than a million U.S. women have received unnecessary and invasive cancer treatments over the last 30 years, thanks to routine mammograms that detected harmless tumors, scientists said Thursday.
The Bureau of National Health Insurance (BNHI) recently announced it will approve a target drug that can suppress EGF (epidermal growth factor) induced colorectal cancer as a first-line treatment starting Dec. 1.
Patients asked to estimate how many lives would be saved through cancer screening or how many hip fractures can be prevented with bone-building medication mostly overestimate the benefits of these preventive measures, according to a New Zealand study.
More than 170 countries Monday adopted what World Health Organization (WHO) chief Margaret Chan called a “game-changing” global pact to combat the illegal tobacco trade.
Taipei-based Orient Europharma Group (OEP) and Japan's Nano Carrier Co. Ltd. inked a new license agreement on a pancreatic cancer drug yesterday, and unveiled their joint investment of NT$700 million (US$24 million) in a new plant to produce cancer drugs.
A drug initially developed to treat some types of cancer now appears to help people suffering from multiple sclerosis (MS), a study said Thursday.
Breast-cancer screening saves lives even though it also picks up cases in some women that would never have caused them a problem, according to a review published in The Lancet medical journal.
The Department of Health (DOH) yesterday gave an order to recall two instant noodle products from South Korea, which were found to contain traces of the cancer-causing substance benzopyrene.